CSI Dry Eye Software Appoints Trudi Charest as Chief Sales Officer

By Staff
Monday, February 26, 2024 12:21 AM CALGARY, Alberta—CSI Dry Eye Software, an emerging artificial intelligence (AI) dry eye software company pioneering AI in dry eye diagnostics and treatment recommendations, announced that it has appointed Trudi Charest as chief sales officer.

Ocular Therapeutix Announces Board of Directors and Leadership Updates

By Staff
Friday, February 23, 2024 12:24 AM BEDFORD, Mass.—Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of therapies for diseases and conditions of the eye, has announced board of directors and leadership updates. Pravin U. Dugel, MD has been named executive chairman, and Jeffrey S. Heier, MD, Peter K. Kaiser, MD, and Sanjay Nayak, MBBS, PhD have been appointed to the ocular management team as chief scientific officer, medical director, and chief strategy officer, respectively.

XP Health Partners With Bell Bank, Adds Cynthia Spitalny as CMO

By Staff
Friday, February 23, 2024 12:15 AM SAN CARLOS, Calif.—XP Health, a company dedicated to democratizing vision care with a digital-first vision benefits platform, announced a new partnership with Bell Bank and the addition of new chief marketing officer Cynthia Spitalny to grow its leadership roster.

Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor

By Staff
Thursday, February 22, 2024 12:15 AM MELBOURNE, Australia—Opthea Limited, a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced the appointment of Arshad M. Khanani, MD, MA, FASRS, as chief medical advisor.

Ocular Therapeutix Appoints Steve Meyers to Chief Commercial Officer

By Staff
Tuesday, February 20, 2024 12:24 AM BEDFORD, Mass.—Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced the appointment of Steve Meyers as chief commercial officer. Meyers has over 20 years of commercial experience, including several buy and bill, specialty pharmacy and innovative technology product launches in highly competitive markets.

Ocuphire Pharma Strengthens Leadership Team With Key Appointments

By Staff
Tuesday, February 20, 2024 12:15 AM FARMINGTON HILLS, Mich.—Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, announced the appointments of Ash Jayagopal, Ph.D., MBA as chief scientific and development officer, and Nirav Jhaveri, CFA, MBA as chief financial officer.

EssilorLuxottica Board of Directors Proposes Nominees to the New Board

By Staff
Friday, February 16, 2024 12:21 AM CHARENTON-LE-PONT, France—EssilorLuxottica's board of directors has decided to propose the reappointment of all current directors to the next annual general meeting to be held on April 30, 2024.

Bollé Safety Names Ellena Wong Vice President of Sales, North America and Latin America

By Staff
Thursday, February 15, 2024 12:15 AM CARLSBAD, Calif.—Bollé Safety is continuing its efforts to expand its presence in the North American market with additional key appointments, most recently announcing the appointment of Ellena Wong to the position of VP of sales for North America and Latin America markets.

National Vision Appoints Susan O’Farrell to Board of Directors

By Staff
Monday, February 12, 2024 12:15 AM DULUTH, Ga.—National Vision Holdings, Inc. announced the appointment of Susan O’Farrell to its board of directors and as a member of its audit committee. O’Farrell is an accomplished financial expert with over 35 years of executive and senior leadership experiene.

Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer

By Staff
Tuesday, February 6, 2024 12:15 AM BOSTON—Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye and presbyopia, announced that it has named Val Kolesnitchenko, MD, as chief scientific officer.

Schneider Announces Addition of Darren Rosenthal as New Territory Sales Manager for Western U.S.

By Staff
Monday, February 5, 2024 12:15 AM FRISCO, Texas—Schneider Optical Machines has announced the addition of Darren Rosenthal in the role of sales director–western US. In this role he will manage the sales of machinery and related technologies to customers in the Rx lens manufacturing space.

Modern Optical International Names Félix Sidès Canadian Sales Director

By Staff
Thursday, February 1, 2024 12:15 AM ROSELLE, Ill.—Modern Optical International has announced that Félix Sidès has joined its senior management team as sales director for Modern Optical Canada. In this role Sidès will focus on expanding Modern’s presence in Canada.

Eyecare Sales Executive Cindy Braden Joins OneSpot Senior Management Team

By Staff
Monday, January 29, 2024 12:21 AM CHICAGO—OneSpot, an eyecare billing software company, announced that Cindy Braden has joined the senior management team as vice president of sales.

ESE International Names Ron Hall Vice President of Sales – Eastern Region

By Staff
Thursday, January 18, 2024 12:18 AM NEW YORK—ESE International has announced the promotion of Ron Hall to vice president of sales – eastern region. Hall previously held the role of southeast regional sales manager and has been with ESE International in a sales and management role for 18 years.

VSP Vision Announces Leadership Updates to Supply Chain and Provider and Industry Solutions

By Staff
Wednesday, January 17, 2024 12:27 AM RANCHO CORDOVA, Calif.—VSP Vision has announced several organizational changes, noting a continued focus on growth and commitment to meeting the needs of clients members and network doctors. Scott Hopeck has been appointed to the new role of chief commercial officer (CCO), where he will lead commercial strategy, including supply chain sales and global business development, to drive value and improved customer experiences across the enterprise. Hopeck will provide end-to-end oversight of VSP Vision’s supply chain business operations while enhancing collaboration and prioritization, the company said.